grant

Prefrontal CRF and the Regulation of Goal Directed Behavior

Organization UNIVERSITY OF WISCONSIN-MADISONLocation MADISON, UNITED STATESPosted 5 Mar 2018Deadline 31 Dec 2027
NIHUS FederalResearch GrantFY2025ACTH-Releasing FactorAD/HDADHDAffectAnimalsAttentionAttention deficit hyperactivity disorderBehaviorBehavior DisordersBrainBrain Nervous SystemCRF ReceptorsCRF-41CRH ReceptorsCatecholaminesCodeCoding SystemCognitionCognitiveCognitive DisturbanceCognitive ImpairmentCognitive declineCognitive function abnormalCommon Rat StrainsCorticoliberinCorticotropin Releasing-Factor ReceptorsCorticotropin-Releasing FactorCorticotropin-Releasing Factor-41Corticotropin-Releasing HormoneCorticotropin-Releasing Hormone ReceptorsCorticotropin-Releasing Hormone-41DevelopmentDiseaseDisorderDistalDisturbance in cognitionDorsomedial NucleusDorsomedial Nucleus of the ThalamusDorsomedial Thalamic NucleusDrug TherapyDrug usageDrugsDysfunctionEncephalonFemaleFunctional disorderFundingGeneticGlutamatesGoalsHumanImmediate MemoryImpaired cognitionImpairmentInfusionInfusion proceduresL-GlutamateLaboratoriesMedial Dorsal NucleusMedicationMediodorsal NucleusMediodorsal Thalamic NucleusMethodologyModern ManNerve CellsNerve Transmitter SubstancesNerve UnitNeural CellNeurobiologyNeurocyteNeuronsNeurotransmittersOvarianPathway interactionsPatientsPharmaceutical PreparationsPharmacological TreatmentPharmacotherapyPhysiopathologyPlayPredominantly Hyperactive-Impulsive Type Attention-Deficit DisorderPredominantly Hyperactive-Impulsive Type Hyperactivity DisorderPrefrontal CortexProestrusRatRats MammalsRattusReceptor ProteinRegulationResearchRoleShort-Term MemorySteroid CompoundSteroidsSympathinsTestingThalamic structureThalamusViral Vectorantagonismantagonistattention modulationattentional modulationbasebasesbehavioral disordercognitive dysfunctioncognitive functioncognitive losscognitive processcorticotropin releasing hormonedevelopmentaldrug interventiondrug treatmentdrug usedrug/agentexecutive controlexecutive functiongene manipulationgenetic approachgenetic manipulationgenetic strategygenetically manipulategenetically perturbglutamatergicimprovedinfusionsinnervationinsightinterdisciplinary approachmalemultidisciplinarymultidisciplinary approachnerve supplyneuralneural mechanismneurobiologicalneurochemicalneurochemistryneuromechanismneuronalnovelpathophysiologypathwaypatient populationpharmaceutical interventionpharmacological interventionpharmacological therapypharmacology interventionpharmacology treatmentpharmacotherapeuticsreceptorsocial rolesustained attentionthalamictreatment strategyworking memory
Sign up free to applyApply link · pipeline · email alerts
— or —

Get email alerts for similar roles

Weekly digest · no password needed · unsubscribe any time

Full Description

Project Summary
The prefrontal cortex (PFC) supports a constellation of ‘executive’ cognitive processes that

guide goal-directed behavior. Dysregulation of PFC-dependent cognition is associated with

numerous behavioral disorders. Currently there is a strong need for improved treatments for PFC-

dependent cognitive dysfunction. However, the development of novel treatments is hindered by

our limited understanding of the neurobiology underlying PFC-dependent cognition. In recent

studies we demonstrated that corticotropin-releasing factor (CRF) neurons in the caudal, but not

rostral, dorsomedial PFC (dmPFC) of male and female rats (outside proestrus) impair two distinct

cognitive processes: working memory and sustained attention. Conversely, inhibition of PFC CRF

neuronal activity or blockade of CRF receptors, locally or globally in the brain, improved PFC-

dependent cognition. Interestingly, the regulatory actions of CRF across these distinct cognitive

processes involve distinct pathways: local release for working memory and extra-PFC release for

sustained attention. The mediodorsal nucleus of the thalamus (MDthal) plays a central role in the

regulation of PFC-dependent function. Preliminary studies indicate that MDthal plays a prominent

role in the sustained attention actions of PFC CRF neurons. We recently demonstrated that the PFC

CRF neurons are comprised of both glutamatergic (CRFGlu, 85%) and GABAergic (CRFGABA, 15%)

subpopulations. The proposed multidisciplinary studies will provide a better understanding of

neural mechanisms that underlie the cognitive actions of PFC CRF neurons. Aim 1 uses recently

developed viral vector-based chemogenetic manipulations to determine the cognitive actions of

CRFGlu and CRFGABA neurons. Aim 2, building on preliminary observations tests the hypothesis that

the sustained attention (an possibly working memory) actions of PFC CRF neurons involve

projections to the

MDthal. Aim 3 examines the neural coding actions of caudal dmPFC

CRFGlu and

CRFGABA across the PFC-MDthal circuit. Collectively, these studies will provide novel insight into the

neurobiology of PFC-dependent cognition. In doing so, these studies may provide a better

understanding of the neural bases of PFC cognitive dysfunction and lead to novel treatment

strategies for PFC-dependent cognitive dysfunction.

Grant Number: 5R01MH116526-08
NIH Institute/Center: NIH

Principal Investigator: CRAIG BERRIDGE

Sign up free to get the apply link, save to pipeline, and set email alerts.

Sign up free →

Agency Plan

7-day free trial

Unlock procurement & grants

Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.

$29.99 / month

  • 🔔Email alerts for new matching tenders
  • 🗂️Track tenders in your pipeline
  • 💰Filter by contract value
  • 📥Export results to CSV
  • 📌Save searches with one click
Start 7-day free trial →